Skip to main content

Advertisement

Log in

Genetic polymorphisms of IL-18 rs1946518 and IL-1β rs16944 are associated with prognosis and survival of acute myeloid leukemia

  • Original Research Paper
  • Published:
Inflammation Research Aims and scope Submit manuscript

Abstract

Background

Though the pathogenesis of AML is still unknown, accumulating evidence revealed that immune response plays a vital part in it. NLRP3 inflammasome as a component of immune system has been found related to several cancers. The single nucleotide polymorphisms (SNPs) of NLRP3 inflammasome genes may be related to pathogenesis and prognosis of AML.

Methods and results

We determined polymorphisms of NLRP3 (rs35829419), CARD8 (rs2043211), IL-1β (rs16944), IL-18 (rs1946518) and NF-κB −94 ins/del ATTG in de novo AML patients to find out whether they play roles in the susceptibility and severity of AML. In our study, 383 AML cases and 300 randomly selected healthy individuals were examined for the polymorphisms and expression of NLRP3 genes. IL-1β (rs16944) polymorphism in different risk AML subgroups was found statistically different, with more GA genotype in favorable-risk cytogenetics group. We also demonstrated that the bone marrow blasts of patients carrying IL-18 (rs1946518) GG or GT genotype were higher than patients of TT genotype. IL-18 plasma level of patients with IL-18 (rs1946518) GT or TT genotype was higher than GG genotype. Moreover, the GT genotype of IL-18 (rs1946518) led to statistically poorer AML-specific survival.

Conclusion

IL-1β (rs16944) and IL-18 (rs1946518) may be served as potential predictors for AML.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;2011(144):646–74.

    Article  Google Scholar 

  2. Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol. 2001;19:666–75.

    CAS  PubMed  Google Scholar 

  3. Kinoshita T, Imamura R, Kushiyama H, Suda T, et al. NLRP3 mediates NF-κB activation and cytokine induction in microbially induced and sterile inflammation. PLoS One. 2015;10(3):e0119179.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Kanneganti TD, Lamkanfi M, Nunez G. Intracellular NOD-like receptors in host defense and disease. Immunity. 2007;27(4):549–59.

    Article  CAS  PubMed  Google Scholar 

  5. Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol. 2009;183(2):787–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Verma D, Bivik C, Farahani E, Synnerstad I, et al. Inflammasome polymorphisms confer susceptibility to sporadic malignant melanoma. Pigment Cell Melanoma Res. 2012;25:506–13.

    Article  CAS  PubMed  Google Scholar 

  7. Ungerbäck J, Belenki D, Jawad ul-Hassan A, Fredrikson M, et al. Genetic variation and alterations of genes involved in NFκB/TNFAIP3- and NLRP3-inflammasome signaling affect susceptibility and outcome of colorectal cancer. Carcinogenesis. 2012;33(11):2126–34.

    Article  PubMed  Google Scholar 

  8. Bouchier-Hayes L, Conroy H, Egan H, Adrain C, Creagh EM, et al. CARDINAL, a novel caspase recruitment domain protein, is an inhibitor of multiple NF-kappa B activation pathways. J Biol Chem. 2001;276(47):44069–77.

    Article  CAS  PubMed  Google Scholar 

  9. Ko DC, Shukla KP, Fong C, Wasnick M, et al. A genome-wide in vitro bacterial-infection screen reveals human variation in the host response associated with inflammatory disease. Am J Hum Genet. 2009;85(2):214–27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Back LK, Farias TD, da Cunha PA, Muniz YC, Ribeiro MC, et al. Functional polymorphisms of interleukin-18 gene and risk of breast cancer in a Brazilian population. Tissue Antigens. 2014;84(2):229–33.

    Article  CAS  PubMed  Google Scholar 

  11. Pratesi C, Bortolin MT, Bidoli E, Tedeschi R, Vaccher E, et al. Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type. Cancer Immunol Immunother. 2006;55:23–30.

    Article  CAS  PubMed  Google Scholar 

  12. Farjadfar A, Mojtahedi Z, Ghayumi MA, Erfani N, Haghshenas MR, et al. Interleukin-18 promoter polymorphism is associated with lung cancer: a case–control study. Acta Oncol. 2006;48:971–62006.

    Article  Google Scholar 

  13. Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, et al. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun. 1999;1(1):3–19.

    Article  CAS  PubMed  Google Scholar 

  14. Qi T, Wang Q, Zheng L, Yang HL, Bao J, et al. Correlation of serum IL-18 level and IL-18 gene promoter polymorphisms to the risk of cervical cancer. NAN Fang Yi Ke Da Xue Xue Bao. 2008;28:754–7.

    CAS  PubMed  Google Scholar 

  15. Blank V, Kourilsky P, Israel A. NF-kappa B and related proteins: Rel/dorsal homologies meet ankyrin-like repeats. Trends Biochem Sci. 1992;17:135–40.

    Article  CAS  PubMed  Google Scholar 

  16. Arisawa T, Tahara T, Shiroeda H, Yamada K, Nomura T, et al. Functional promoter polymorphisms of NFκB1 influence susceptibility to the diffuse type of gastric cancer. Oncol Rep. 2013;30:3013–9.

    CAS  PubMed  Google Scholar 

  17. Fan Y, Yu W, Ye P, Wang H, Wang Z, et al. NF-KB1 insertion/deletion promoter polymorphism increases the risk of advanced ovarian cancer in a Chinese population. DNA Cell Biol. 2008;30:241–5.

    Article  Google Scholar 

  18. Zhang P, Wei Q, Li X, Wang K, Zeng H, et al. A functional insertion/deletion polymorphism in the promoter region of the NF-KB1 gene increases susceptibility for prostate cancer. Cancer Genet Cytogenet. 2009;191:73–7.

    Article  CAS  PubMed  Google Scholar 

  19. Lin SC, Liu CJ, Yeh WI, Lui MT, Chang KW, et al. Functional polymorphism in NF-KB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers. Cancer Lett. 2006;243:47–54.

    Article  CAS  PubMed  Google Scholar 

  20. Jin J. Chinese guide for refractory AML patients. Chin J Hematol. 2011;12(12):887–8.

    Google Scholar 

  21. Verma D, Särndahl E, Andersson H, Eriksson P, Fredrikson M, et al. The Q705K polymorphism in NLRP3 is a gain-of-function alteration leading to excessive interleukin-1b and IL-18 production. PLoS One. 2012;7(4):e34977.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Ungerbäck J, Belenki D, Jawad ul-Hassan A, Fredrikson M, Fransén K, et al. Genetic variation and alterations of genes involved in NFkappaB/TNFAIP3- and NLRP3-inflammasome signaling affect susceptibility and outcome of colorectal cancer. Carcinogenesis. 2012;2012(33):2126–34.

    Article  Google Scholar 

  23. Arend WP, Palmer G, Gabay C. IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev. 2008;223:20–38.

    Article  CAS  PubMed  Google Scholar 

  24. Alexandrakis MG, Passam FH, Sfiridaki K, Moschandrea J, et al. Interleukin-18 in multiple myeloma patients: serum levels in relation to response to treatment and survival. Leuk Res. 2004;28:259–66.

    Article  CAS  PubMed  Google Scholar 

  25. Tsai HT, Hsin CH, Hsieh YH, Tang CH, Yang SF, Lin CW, et al. Impact of interleukin-18 polymorphisms −607A/C & −137G/C on oral cancer occurrence and clinical progression. PLoS One. 2013;8(12):e83572.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Takada T, Suzuki E, Morohashi K, Gejyo F, et al. Association of single nucleotide polymorphisms in the IL-18 gene with sarcoidosis in a Japanese population. Tissue Antigens. 2002;60(1):36–42.

    Article  CAS  PubMed  Google Scholar 

  27. Sáenz-López P, Carretero R, Vazquez F, Martin J, Sánchez E, et al. Impact of interleukin-18 polymorphisms-607 and -137 on clinical characteristics of renal cell carcinoma patients. Hum Immunol. 2010;71:309–13.

    Article  PubMed  Google Scholar 

  28. Ying B, Shi Y, Pan X, Song X, Huang Z, et al. Association of polymorphisms in the human IL-10 and IL-18 genes with rheumatoid arthritis. Mol Biol Rep. 2011;38(1):379–85.

    Article  CAS  PubMed  Google Scholar 

  29. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 2000;404:398–402.

    Article  CAS  PubMed  Google Scholar 

  30. Loh M, Koh KX, Yeo BH, Song CM, et al. Meta-analysis of genetic polymorphisms and gastric cancer risk: variability in associations according to race. Eur J Cancer. 2009;45:2562–8.

    Article  CAS  PubMed  Google Scholar 

  31. Xue H, Lin B, Ni P, Xu H, Huang G. Interleukin-1B and interleukin-1 RN polymorphisms and gastric carcinoma risk: a meta-analysis. J Gastroenterol Hepatol. 2010;25:1604–17.

    Article  PubMed  Google Scholar 

  32. Jin L, Yuan RQ, Fuchs A, Yao Y, Joseph A, et al. Expression of interleukin-1beta in human breast carcinoma. Cancer. 1997;80:421–34.

    Article  CAS  PubMed  Google Scholar 

  33. Lewis AM, Varghese S, Xu H, Alexander HR. Interleukin 1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment. J Transl Med. 2006;4:48.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Guzman ML, Neering SJ, Upchurch D, Grimes B, Howard DS, Rizzieri DA, et al. Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells. Blood. 2001;98(8):2301–7.

    Article  CAS  PubMed  Google Scholar 

  35. Kagoya Y, Yoshimi A, Kataoka K, Nakagawa M, Kumano K, et al. Positive feedback between NF-kappaB and TNF-alpha promotes leukemia-initiating cell capacity. J Clin Investig. 2014;124(2):528–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Keutgens A, Robert I, Viatour P, Chariot A. Deregulated NF-kappaB activity in haematological malignancies. Biochem Pharmacol. 2006;72(9):1069–80.

    Article  CAS  PubMed  Google Scholar 

  37. Zhou J, Ching YQ, Chng WJ. Aberrant nuclear factor-kappa B activity in acute myeloid Leukemia: from molecular pathogenesis to therapeutic target. Oncotarget. 2015;6(8):5490–500.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Riemann K, Becker L, Struwe H, Rübben H, Eisenhardt A, Siffert W. Insertion/deletion polymorphism in the promoter of NFκB1 as a potential molecular marker for the risk of recurrence in superficial bladder cancer. Int J Clin Pharmacol Ther. 2007;45(8):423–30.

    Article  CAS  PubMed  Google Scholar 

  39. Xu L, Huang S, Chen W, Song Z, Cai S. NFKB1 −94 insertion/deletion polymorphism and cancer risk: a meta-analysis. Tumor Biol. 2014;35(6):5181–7.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from National Natural Science Foundation of China (No. 81470319, No. 81170515).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daoxin Ma.

Ethics declarations

Conflict of interest

We declare that there is no conflict of interest.

Additional information

Responsible Editor: John Di Battista.

H. Wang, M. Hua and S. Wang contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, H., Hua, M., Wang, S. et al. Genetic polymorphisms of IL-18 rs1946518 and IL-1β rs16944 are associated with prognosis and survival of acute myeloid leukemia. Inflamm. Res. 66, 249–258 (2017). https://doi.org/10.1007/s00011-016-1012-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00011-016-1012-4

Keywords

Navigation